ACM
NUVB icon

Aster Capital Management’s Nuvation Bio NUVB Stock Holding History

Aster Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,426
Closed -$12.8K – 1179
2025
Q4 		$12.8K Buy
+1,426
New +$8.83K 0.01% 708

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aster Capital Management's NUVB Position: Q1 2026 in Review

Aster Capital Management sold out of Nuvation Bio (NUVB) in Q1 2026, closing a stake of 1,426 shares — an estimated $12.8K sold.

Aster Capital Management first reported a position in NUVB in Q4 2025 and held it in 1 quarter. The position peaked at $12.8K in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Aster Capital Management reported no remaining Nuvation Bio position as of Q1 2026 after selling out during the quarter.
  • Aster Capital Management sold 1,426 Nuvation Bio shares in Q1 2026, an estimated $12.8K.
  • Aster Capital Management first reported a position in Nuvation Bio in Q4 2025 and held it in 1 quarter.
  • Aster Capital Management's Nuvation Bio position peaked at $12.8K in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.